MHRAapproval72% confidence
Clinical trials for medicines: modifying a clinical trial approval
Source: MHRA
Why This Matters
Why this matters: sets a approval precedent in the same sub-indication (pain) as Hikma.
Regulatory Analysis
Guidance on the various types of modifications that can be made to a clinical trial approval.
Supporting Context
- Therapeutic area
- Pain Management · Opioid
- Sub-indication
- Pain
Related signal: Hikma's Roxicet ANDA089351 Receives Abbreviated Approval from FDA